TheStreet | 2:09 | Fri, Aug 3, 2012 11:18 AM EDT | 15 views
Now Playing
Up Next
3:53
1:51
4:04
2:40
2:58
3:55
1:30
5:49
4:43
4:59
1:41
4:25
5:00
2:00
3:34
2:39
3:32
What NOT to buy on Black Friday
Secrets from the Garage Sale Millionaire
Equity Markets Still Look Attractive in 2013: UBS's Zirin
Facebook's Mobile Strategy in 2013
Global Grind: The Economy Will Be Bad Everywhere in 2013
Fri, Aug 3, 2012 11:18 AM EDT - TheStreet 2:09
Senior columnist Adam Feuerstein says post-FDA approval trading is the next big thing to watch in biotech.
